RIZZI, Anna
 Distribuzione geografica
Continente #
NA - Nord America 7.838
EU - Europa 1.703
AS - Asia 1.163
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
OC - Oceania 2
Totale 10.712
Nazione #
US - Stati Uniti d'America 7.816
CN - Cina 683
UA - Ucraina 492
DE - Germania 416
TR - Turchia 302
GB - Regno Unito 242
IT - Italia 239
SG - Singapore 150
FI - Finlandia 117
SE - Svezia 91
RU - Federazione Russa 31
BE - Belgio 26
CA - Canada 22
FR - Francia 21
CZ - Repubblica Ceca 10
IN - India 10
IR - Iran 7
HK - Hong Kong 5
PL - Polonia 5
A2 - ???statistics.table.value.countryCode.A2??? 3
HR - Croazia 3
BR - Brasile 2
GR - Grecia 2
NL - Olanda 2
NO - Norvegia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
IQ - Iraq 1
JP - Giappone 1
KW - Kuwait 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 10.712
Città #
Fairfield 1.156
Woodbridge 1.108
Houston 656
Jacksonville 574
Ann Arbor 564
Ashburn 546
Chandler 513
Seattle 435
Wilmington 409
Cambridge 379
Izmir 185
Nanjing 153
Beijing 144
Princeton 113
Milan 103
San Diego 101
Boardman 100
Singapore 97
Shanghai 83
New York 74
Nanchang 60
Ferrara 57
Dearborn 54
Shenyang 47
Hebei 35
Bremen 34
Munich 28
Auburn Hills 25
Brussels 25
Jiaxing 24
Mountain View 24
San Mateo 24
Falls Church 22
Mcallen 22
Norwalk 21
Tianjin 21
Changsha 19
Jinan 17
Los Angeles 17
Montréal 17
Addison 16
Philadelphia 16
Zhengzhou 16
Redwood City 15
Helsinki 13
Kunming 13
Tappahannock 13
Indiana 12
London 11
Ningbo 10
Washington 9
Orange 8
Verona 8
Bologna 7
Düsseldorf 7
Lanzhou 7
Des Moines 6
Guangzhou 6
Hounslow 5
Olomouc 5
Redmond 5
Warsaw 5
Ardabil 4
Augusta 4
Brno 4
Fuzhou 4
Hong Kong 4
Monmouth Junction 4
Bari 3
Changchun 3
Edinburgh 3
Ferrara di Monte Baldo 3
Hangzhou 3
Hefei 3
Leawood 3
Prescot 3
San Francisco 3
Taizhou 3
Toronto 3
Zagreb 3
Bondeno 2
Bonn 2
Boston 2
Chicago 2
Chiswick 2
Islington 2
Juiz De Fora 2
La Canada Flintridge 2
Leicester 2
New Bedfont 2
Oderzo 2
Pune 2
Scorzè 2
Turin 2
Wandsworth 2
Yellow Springs 2
Aberdeen 1
Acton 1
Amsterdam 1
Athens 1
Totale 8.395
Nome #
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ. 159
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 159
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 157
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 144
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 141
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 140
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 137
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 134
A new selective antagonist of the nociceptin receptor 133
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 132
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 131
Pharmacological characterization of nociceptin receptor: an in vitro study 131
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 129
A new ligand for the urotensin II receptor 126
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 125
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 125
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 124
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 123
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 122
Effects of vasoactive agents in healthy and diseased human saphenous veins 120
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 117
Ala scan analogues of HOE 140. Synthesis and biological activities 117
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 117
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 116
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 116
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 115
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 113
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 113
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 113
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 112
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 112
null 110
Pharmacological characterization of tachykinin tetrabranched derivatives 110
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 108
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 107
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 107
Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies. 107
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 107
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 107
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 106
Structure-activity study at positions 3 and 4 of human neuropeptide S. 106
B1 and B2 kinin receptors in various species 105
null 105
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 104
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 104
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 104
Pharmacological characterisation of novel kinin B2 receptor ligands 103
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A 102
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 102
Characterization of endothelin receptors in the human umbilical artery and vein 102
Pharmacology of the Kallikrein-Kinin system 102
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 102
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 101
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 101
Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: An in vitro study on human, rabbit and pig vascular B2 receptors 101
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 101
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 100
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 100
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 99
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 98
Receptors for kinins in the human isolated umbilical vein. 97
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 96
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 96
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 96
In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol 96
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 95
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 95
Structure-activity relationship study on human urotensin II 95
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery 91
Nociceptin/orphanin FQ receptor ligands, 91
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 91
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 91
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 90
Endogenous nociceptin signaling and stress-induced analgesia 90
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 89
Anxiolytic-like effect of neuropeptide S in the rat defensive burying. 89
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 88
Pharmacology of nociceptin and its receptor: a novel therapeutic target 87
null 87
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 86
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 86
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 85
null 84
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 83
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 83
Characterization of the human vascular kinin B2 receptor by binding assays. 80
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 80
null 79
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 75
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 75
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 74
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 74
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 73
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 73
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 69
MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor 65
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes 65
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS. 64
Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor 61
Pharmacological characterization of the nociceptin receptors in the mouse: receptor binding, bioassay and behavioral studies 57
Totale 10.285
Categoria #
all - tutte 43.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.459


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.663 379 96 89 390 198 313 245 275 231 241 133 73
2020/20211.470 136 152 60 205 75 160 46 178 31 171 188 68
2021/20221.209 45 117 98 81 65 48 64 80 50 104 112 345
2022/20231.252 119 58 58 162 211 169 97 106 162 5 61 44
2023/2024646 73 82 30 16 35 131 24 57 9 12 21 156
2024/202563 63 0 0 0 0 0 0 0 0 0 0 0
Totale 10.812